AVA-101

Avalanche shares continute to fall off a cliff as company ditches eye drug trial
BioPharma Dive
Fri, 08/14/15 - 10:10 am
Avalanche Biotechnologies
AVA-101
wet age-related macular degeneration
Avalanche Biotech's stock loses half its value after trial results raise concerns
Marketwatch
Tue, 06/16/15 - 09:11 am
Avalanche Biotechnologies
wet age-related macular degeneration
AVA-101